Facebook
Twitter
Telegram
Report an ErrorClearside Biomedical Financial Ratios 2011-2024 | CLSD
Annual Financial Ratios Clearside Biomedical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.1 | -1.9 | 248.1 | -8.5 | -4.4 | -0.4 | -2.7 | -3.7 | - | - | - | - | - |
P/S |
12.3 | 46.7 | 3.2 | 19.5 | 62.9 | 1198.6 | 467.3 | 182.8 | - | - | - | - | - |
EPS |
-0.5 | -0.6 | 0.0 | -0.4 | -0.8 | -2.7 | -2.3 | -2.0 | -7.5 | -5.9 | - | - | - |
EV (Enterprise Value) |
122 M | 54.4 M | 67.8 M | 147 M | 130 M | 48.4 M | 171 M | 73.4 M | 37.4 M | 21.2 M | 12.9 M | - | - |
EBITDA per Share |
-0.4 | -0.5 | -0.01 | -0.38 | -0.788 | -2.69 | -2.3 | -1.92 | - | - | - | - | - |
EV/EBITDA |
-73.5 | -5.8 | -3.9 | -0.8 | -3.2 | -4.6 | - | - | - | - | - | ||
PEG |
-0.0 | -0.0 | -6.79 | -0.16 | -0.06 | 0.03 | 0.15 | 0.11 | - | - | - | - | - |
P/B |
-6.4 | 5.8 | 2.5 | 17.6 | 12.2 | 1.5 | 7.5 | 1.3 | - | - | - | - | - |
P/CF |
-5.6 | -4.6 | -8.7 | -11.7 | -5.0 | -0.5 | -3.1 | -4.2 | - | - | - | - | - |
ROE % |
204.15 | -310.62 | 0.99 | -207.81 | -275.79 | -350.63 | -275.39 | -36.12 | - | - | - | - | - |
ROA % |
-95.49 | -64.22 | 0.88 | -94.24 | -114.92 | -187.71 | -145.64 | -30.52 | - | - | - | - | - |
ROCE % |
156.13 | -285.44 | -1.65 | -204.67 | -190.92 | -246.54 | -216.53 | -31.73 | - | - | - | - | - |
Current Ratio |
0.7 | 1.3 | 8.7 | 1.8 | 2.3 | 4.1 | 2.9 | 15.6 | - | - | - | - | - |
DSO |
- | - | 61.7 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1673.3 | 1781.2 | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 61.7 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-1673.3 | -1781.2 | 61.7 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Clearside Biomedical
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.15 | -0.15 | -0.15 | - | -0.13 | -0.13 | -0.13 | - | -0.08 | -0.11 | -0.13 | - | -0.05 | -0.13 | -0.07 | -0.07 | -0.17 | -0.15 | -0.45 | -0.68 | -0.75 | -0.65 | -0.62 | -0.65 | -0.72 | -0.54 | -0.41 | -0.45 | -0.28 | -0.62 | -2.05 | -1.95 | -1.31 | -2.36 | -2.07 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.12 | - | -0.11 | -0.13 | -0.13 | - | -0.08 | -0.1 | -0.15 | - | -0.05 | -0.12 | -0.06 | - | -0.16 | -0.15 | -0.45 | - | -0.74 | -0.65 | -0.61 | - | -0.71 | -0.54 | -0.4 | - | -0.26 | -0.62 | -2.01 | - | -1.26 | -2.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-130.68 | -245.00 | -459.06 | -97.26 | -124.64 | -109.82 | -110.39 | -102.18 | -129.94 | -130.33 | -164.47 | -126.65 | -154.40 | -185.21 | -170.94 | -275.79 | -339.65 | -382.14 | -418.38 | -350.63 | -336.03 | -320.59 | -297.26 | -275.39 | -211.89 | -134.15 | -76.95 | -36.12 | -8.50 | 8.86 | 30.51 | 38.11 | 24.01 | 14.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-84.98 | -72.11 | -74.29 | -60.67 | -78.52 | -82.31 | -78.22 | -65.59 | -78.18 | -72.92 | -81.39 | -57.44 | -69.00 | -80.82 | -72.45 | -114.92 | -152.40 | -182.09 | -207.60 | -187.71 | -179.40 | -170.57 | -157.67 | -145.64 | -116.33 | -77.71 | -49.71 | -30.52 | -43.65 | -53.50 | -72.78 | -66.36 | -41.80 | -25.30 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-116.83 | -207.99 | -385.22 | -91.41 | -118.81 | -109.94 | -110.43 | -108.07 | -135.82 | -136.18 | -168.08 | -123.53 | -180.61 | -209.93 | -196.86 | -244.61 | -346.03 | -390.38 | -428.53 | -259.58 | -344.54 | -328.07 | -303.25 | -196.53 | -203.93 | -126.39 | -69.93 | -22.11 | -12.90 | 3.71 | 25.03 | 23.31 | 23.31 | 14.10 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.7 | 0.9 | 1.1 | 1.3 | 1.5 | 5.6 | 8.3 | 8.7 | 2.9 | 3.1 | 2.6 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 6.5 | 6.5 | 6.5 | 6.5 | 2.0 | 2.0 | 2.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
60.4 | - | - | - | 42.2 | 14.6 | 1314.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1205.8 | 745.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
60.4 | - | - | - | 42.2 | 14.6 | 1314.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-1145.5 | -745.4 | - | - | 42.2 | 14.6 | 1314.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency